 Treatment malignant pleural effusions doxorubicin hydrochloride-containing poly L-lactic acid treatment malignant pleural effusions doxorubicin hydrochloride Adriamycin poly L-lactic acid microspheres ADR-MS vitro percent percent release times ADR ADR-MS days intrapleural administration ADR-MS patients ADR dose mg ADR effusions weeks ADR concentrations serum small consistent minimal transpleural absorption ADR results slow release ADR pleural cavity amount drained ADR percent dose cases malignant cells effusion treatment complications procedure patients systemic symptoms patient months patients alive months reaccumulation effusion local administration ADR-MS localized high systemic low concentration ADR patient quality life